dihexa and autism | Peptide Synthetic | High Purity Emerging Epigenetic Therapeutics and Diagnostics

BCM-7 is a septa-peptide that is catabolised by the enzyme dipeptidyl-peptidase IV in normal individuals, but which may be absent or defective in autistic people and possibly in people suffering from schizophrenia and also diabetes (J

A peptide that previously dissolved easily but now requires extensive mixing may have undergone structural changes

BPC 157() (VEGF, EGF),

As research progresses, these insights may contribute to a better understanding of how peptides influence recovery and regeneration at the cellular level.

HIGH-QUALITY MANUFACTURING: Produced in a GMP-certified lab with rigorous quality standards for maximum reliability and consistency.